SC
LLY icon

Swan Capital’s Eli Lilly LLY Stock Holding History

Swan Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Sell
150
-4
-3% -$4.05K 0.05% 46
2025
Q4 		$166K Sell
154
-1
-0.6% -$956 0.06% 43
2025
Q3 		$118K Buy
155
+2
+1% +$1.49K 0.05% 49
2025
Q2 		$119K Buy
153
+17
+13% +$13.2K 0.05% 45
2025
Q1 		$112K Hold
136
– – 0.05% 46
2024
Q4 		$105K Sell
136
-2
-1% -$1.66K 0.05% 47
2024
Q3 		$122K Buy
138
+2
+1% +$1.8K 0.06% 45
2024
Q2 		$123K Buy
+136
New +$109K 0.07% 42

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Swan Capital's LLY Position: Q1 2026 in Review

Swan Capital reduced its Eli Lilly (LLY) stake by 2.6% in Q1 2026, selling an estimated $4.05K and leaving 150 shares worth $138K. The position accounts for 0.05% of the portfolio, ranked #46.

Swan Capital first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $166K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Swan Capital held 150 shares of Eli Lilly worth $138K as of Q1 2026.
  • Swan Capital sold 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
  • Eli Lilly made up 0.05% of Swan Capital's portfolio in Q1 2026, its #46 holding.
  • Swan Capital first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • Swan Capital's Eli Lilly position peaked at $166K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.